MARTON MEDICAL PRACTICE — All Prescriptions & Medications — Page 13
Practice Code: P81054 | BLACKPOOL, FY3 9ES
Showing results 601-650 of 657
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Betamethasone sodium phosphate | 13 | 1,300 | £171 | +5.7% ▲ |
| Goserelin acetate | 13 | 13 | £1.1K | -70.5% ▼ |
| Lanthanum carbonate | 13 | 1,170 | £2.5K | +58.5% ▲ |
| Tube feed 1.2 kcal/ml with fibre, higher protein (0914011) | 13 | 534.0K | £9.5K | +19.2% ▲ |
| 13 | 390 | £601 | +78.4% ▲ | |
| 13 | 130 | £422 | +235.8% ▲ | |
| 13 | 62 | £108 | +41.2% ▲ | |
| 13 | 13 | £740 | +119.1% ▲ | |
| 13 | 720 | £524 | +79.7% ▲ | |
| 13 | 2,000 | £324 | -66.6% ▼ | |
| Nizatidine | 12 | 356 | £172 | -65.1% ▼ |
| Acetylcysteine | 12 | 360 | £63 | -83.2% ▼ |
| Doxepin | 12 | 336 | £862 | -7.7% ▼ |
| Perampanel | 12 | 168 | £798 | -44.6% ▼ |
| Sirolimus | 12 | 360 | £2.1K | +1.5% vs avg |
| Sodium feredetate | 12 | 5,400 | £154 | -58.1% ▼ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 12 | 50.3K | £951 | -82.9% ▼ |
| RtS 2.4 kcal/ml milkshake lower volume with fibre (0913021) | 12 | 42.0K | £1.6K | +28.0% ▲ |
| Loteprednol etabonate | 12 | 70 | £73 | +29.7% ▲ |
| Lodoxamide trometamol | 12 | 120 | £60 | +96.7% ▲ |
| Cocois | 12 | 780 | £135 | -12.6% ▼ |
| 12 | 90 | £331 | +34.9% ▲ | |
| 12 | 115 | £239 | -72.7% ▼ | |
| 12 | 28 | £181 | -66.4% ▼ | |
| 12 | 360 | £1.8K | -5.1% ▼ | |
| 12 | 1,075 | £146 | -9.0% ▼ | |
| Finerenone | 11 | 448 | £558 | +1.1% vs avg |
| Olmesartan medoxomil | 11 | 308 | £20 | -84.0% ▼ |
| Aclidinium bromide/formoterol | 11 | 11 | £340 | -68.7% ▼ |
| Valproic acid | 11 | 330 | £29 | -24.8% ▼ |
| Opicapone | 11 | 330 | £649 | -42.5% ▼ |
| Hydrocortisone sodium phosphate | 11 | 22 | £46 | +163.6% ▲ |
| Phentolamine/aviptadil | 11 | 55 | £523 | +54.1% ▲ |
| Chlorhexidine gluconate | 11 | 5,250 | £84 | -62.8% ▼ |
| 11 | 165 | £19 | -59.1% ▼ | |
| 11 | 150 | £495 | -64.2% ▼ | |
| 11 | 13 | £748 | +164.5% ▲ | |
| 11 | 470 | £1.6K | -54.8% ▼ | |
| 11 | 490 | £60 | +7.5% ▲ | |
| 11 | 290 | £685 | -46.3% ▼ | |
| 11 | 990 | £1.8K | -13.6% ▼ | |
| Glycopyrronium/formoterol | 10 | 10 | £309 | -60.5% ▼ |
| Acrivastine | 10 | 780 | £229 | -18.8% ▼ |
| Ethosuximide | 10 | 4,000 | £3.3K | -32.2% ▼ |
| Phenobarbital | 10 | 560 | £17 | -67.5% ▼ |
| Entacapone | 10 | 786 | £160 | -34.4% ▼ |
| Mercaptopurine | 10 | 420 | £224 | -35.4% ▼ |
| Magnesium glycerophosphate | 10 | 924 | £443 | -27.2% ▼ |
| Gel OTC glucose for diabetic hypo treatment (0913541) | 10 | 705 | £66 | -16.2% ▼ |
| Ivermectin | 10 | 480 | £279 | -53.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.